cellule staminali
Post-PCI Selection of Antithrombotic Therapy
Post-PCI Selection of Antithrombotic Therapy Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention. By John P. Vavalle, MD, and Robert A. Harrington, MD Since the introduction of percutaneous coronary intervention (PCI) più di 3 decades ago, the rates of procedural success and associated Per saperne di più…
Terapia con cellule staminali
Clopidogrel bioequivalence study.Sample.
QUOTATION CLOPIDOGREL 75 Tablets Study design: a two-period, crossover, single-dose bioequivalence study in 36 healthy volunteers of both sexes, clinical confinement during 10 hours before and 32 hours after the dose, 20 blood samples per subject per period will be collected before dosing and till 32 hours after the Per saperne di più…